Literature DB >> 7091162

Parallel adrenal and renal abnormalities in young patients with essential hypertension.

G H Williams, M L Tuck, J M Sullivan, R G Dluhy, N K Hollenberg.   

Abstract

To determine whether the previously described abnormalities in adrenal secretion and renal blood flow in essential hypertension are associated, we examined the responses to the relevant systems in 18 patients with essential hypertension. Young patients, under 30 years of age, were studied to minimize the likelihood that the phenomena were secondary to long-standing hypertension. To achieve a wide span of sodium balance, studies were performed during a high (200 mEq) sodium intake, a restricted (10 mEg) sodium intake and a restricted sodium intake supplemented by a further short-term diuretic-induced volume deficit (furosemide, 180 to 300 mg, to reduce body weight by 1 to 1.5 kg). The indexes measured included cardiac output (indocyanine green indicator dilution), plasma volume (125 I albumin space), renal blood flow (radioxenon transit), plasma renin activity and aldosterone levels and aldosterone secretory rate. All of these variables, with the exception of blood pressure and total peripheral resistance, were within the normal range during the two diets. However, the aldosterone secretory response to diuretic-induced volume depletion on a low-sodium diet was clearly blunted in nine subjects. These nine subjects (abnormal responders) had a virtually absent aldosterone increment (23 +/- 34 micrograms per 24 hours) compared with the normal responders (502 %/- 70 micrograms per 24 hours). In addition, renal blood flow was significantly higher in these same nine subjects during both a high sodium intake (434 +/- 19 versus 342 +/- 26 ml/100 g per minute) and a restricted sodium intake /446 +/- 11 versus 285 +/- 39 ml/100 g per minute). Yet, there were no significant differences between these two groups in sodium or potassium balance, blood pressure, plasma volume, cardiac index or plasma renin activity during a high or low sodium intake. Normally, control of both aldosterone release by the adrenal and renal perfusion is dominated by angiotensin; an apparently blunted response of both systems suggests that there may be a generalized abnormality in the way angiotensin interacts with its target tissues in many young patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7091162     DOI: 10.1016/0002-9343(82)90851-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses.

Authors:  Bei Sun; Jonathan S Williams; Luminita Pojoga; Bindu Chamarthi; Jessica Lasky-Su; Benjamin A Raby; Paul N Hopkins; Xavier Jeunemaitre; Nancy J Brown; Claudio Ferri; Gordon H Williams
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2011-04-13       Impact factor: 1.636

2.  Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome.

Authors:  Qi Fu; Tiffany B VanGundy; Shigeki Shibata; Richard J Auchus; Gordon H Williams; Benjamin D Levine
Journal:  Hypertension       Date:  2010-05-17       Impact factor: 10.190

3.  A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II.

Authors:  Bindu Chamarthi; Jonathan S Williams; Gordon H Williams
Journal:  J Hypertens       Date:  2010-05       Impact factor: 4.844

4.  Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.

Authors:  J Redgrave; S Rabinowe; N K Hollenberg; G H Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

Review 5.  Intrarenal angiotensinogen: localization and regulation.

Authors:  J R Ingelfinger; H Schunkert; K E Ellison; M Pivor; W M Zuo; R Pratt; V J Dzau
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

Review 6.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

7.  Mechanism of sodium modulation of glomerular angiotensin receptors in the rat.

Authors:  A Bellucci; B M Wilkes
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

Review 8.  Pathogenesis of the essential hypertensions.

Authors:  J G Mongeau
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

9.  Cardiovascular and adrenal sensitivity to angiotensin II in essential hypertension.

Authors:  G Wambach; U Meiners; G Bönner; A Konrads; A Helber
Journal:  Klin Wochenschr       Date:  1984-12-03

10.  [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].

Authors:  K O Stumpe
Journal:  Klin Wochenschr       Date:  1985-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.